Compare Novavax Inc (NVAX) vs SMX Security Matters plc (SMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs SMX Security Matters plc — how do they compare? Novavax Inc trades at $12.75 (market cap $1.82B), while SMX Security Matters plc trades at $3.79 (market cap $4.13M). The key difference: Novavax Inc is far larger — about 440.7× SMX Security Matters plc's market cap, and Novavax Inc is trading nearer its 52-week high, SMX Security Matters plc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Novavax Inc for 59 Days and SMX Security Matters plc for 21 Days on average.
| NVAX | SMX | |
|---|---|---|
Market Cap | $1.82B | $4.13M |
Volume | 6,198,505 | 124,362 |
Sector | Health | Industrials |
52-Week High | $12.75 | $74.08K |
52-Week Low | $6.22 | $3.79 |
Typical Hold Time | 59 Days | 21 Days |
Enterprise Value | $1.39B | -$27.20M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novavax (NVAX) trades at $11.01, down 1.87% on the day, with a bullish technical signal from moving averages and a strong buy consensus from analysts (73.9% buy ratings). The company reported a net income of $440.3M in 2025, a significant turnaround from prior losses, though 2026 projections show a return to negative margins. Recent news highlights regulatory approvals for its COVID-19 vaccine and strategic pivots toward its Matrix-M adjuvant platform through partnerships.
The outlook is mixed: near-term catalysts include partnership-driven growth and vaccine approvals, but persistent cash burn and projected 2026 losses pose risks. Investor sentiment is buoyed by recent earnings beats and strategic shifts, yet execution on profitability remains critical for sustained upside.
SMX trades at $3.79, down 2.82% today, amid bearish technical signals from moving averages. The company reported no revenue in 2025, with a net loss of $169.18M and negative cash flow from operations, though financing activities provided a net cash inflow. Recent news highlights its Digital Material Passport platform and media coverage from outlets like Forbes and Boston Herald.
The outlook is highly speculative given the lack of revenue and deep losses. Investment hinges on future commercialization of its recycling technology. Key risks include execution challenges, cash burn, and competitive pressures. Analyst sentiment is not available, but institutional backing via financing offers some support amid fundamental weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About SMX Security Matters plc
SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →
